As per this study the Global Hematology Diagnostics Market was valued USD XX MN (by revenue) in 2021 and is anticipated to reach USD XX MN by 2028 with a CAGR of XX%.
Hematology diagnostics deals with the identification of blood cell and blood-related diseases. It includes counting of red blood cells, white blood cells, and platelets. Hematology diagnostics products include instruments and consumables. Additionally, consumables include reagents, stains, controls and calibrators, and instruments include analyzers and flow cytometers.
The rising incidence of blood disorders along with an increasing number of blood donors across the globe is driving the market growth. Additionally, growing technological advancements such as integration of hematology analyzers with flow cytometry are further boosting the market growth. On the other hand, the slow penetration of advanced hematology instruments in emerging countries may hamper market growth. Whereas, the increasing use of automated hematology analyzers and emergence of microfluidics technology is expected to create potential opportunity during the forecast period.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter’s five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of hematology diagnostics.
The broad hematology diagnostics market has been sub-grouped into product, type, end-user and test type. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
- Flow Cytometers
By Test Type
- Diagnostic Labs
- Blood count
- Platelet Function
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for hematology diagnostics in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global Hematology Diagnostics Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the hematology diagnostics market include Abbott, Beckman Coulter, Bio-Rad Laboratories, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Horiba, Mindray, Nihon Kohden, Siemens Healthcare and Sysmex Corporation. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand.